| Subject: | FDA Issues Important Notice About RabAvert Rabies Vaccine Kits |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 20 Apr 2010 - 11:00 am |
| The Food and Drug Administration (FDA) is informing healthcare professionals that Novartis Vaccines has implemented a voluntary market withdrawal of the following: RabAvert Kit Batch #458011A (Expires April, 2013)Diluent Vial Batch #927011 (Expires April, 2014)The withdrawal of this single batch of RabAvert is due to the fact that the stopper and the metal crimp can dislodge from the vial completely when removing the protective cap. A low percentage of diluent vials exhibit this... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|